Boston Scientific to Showcase Innovative Medical Technologies at the 4th China International Import Expo, Advancing Healthy China Initiative

SHANGHAI, Oct. 20, 2021 /PRNewswire/ -- As the countdown to the fourth China International Import Expo (CIIE) reaches two weeks, global medical technology leader Boston Scientific (NYSE:BSX) announced it will participate in the expo for the third time under the theme "New Model – New Ecosystem: Building a Community of Health." The company will share cutting-edge global innovative technologies with Chinese healthcare professionals and patients, and highlight the public-benefit achievements from previous CIIEs that have accelerated the transformation of "exhibits into commercial products."

As a loyal partner of the Shanghai CIIE, Boston Scientific has expanded to 400square meterThe exhibition booth will be featured in the Medical Devices and Healthcare Products Exhibition Area of Hall 8.1 at the National Exhibition and Convention Center (Shanghai), showcasing innovative solutions spanning six key areas: vascular health, atrial fibrillation treatment and stroke prevention, heart failure management and sudden cardiac death prevention, urology and pelvic floor health, single-use endoscopy, and interventional oncology. During the event, a wide array of products making their “CIIE debut,” pre-launch releases, and cutting-edge technologies that are winners or nominees of the Galien Award—acclaimed as the “Nobel Prize of the Medical and Pharmaceutical Industry”—will all take center stage at the CIIE. Leveraging digital and immersive interactive experiences, the booth will showcase the pioneering excellence of a global leader in minimally invasive interventional innovation.

Ms. Zhang Jun, President of Boston Scientific Greater China, stated: “The company attaches great importance to the China International Import Expo (CIIE) as a high-level platform for opening up. Benefiting from the CIIE’s ‘multiplier’ exposure effect and ‘accelerator’ boost, Boston Scientific has successfully accelerated the market entry of several globally leading innovative products into China, enabling them to benefit Chinese patients at the earliest opportunity. We greatly look forward to continuing to leverage the CIIE platform to share China’s opportunities and speed with more industry partners, bringing more innovative medical products to China as swiftly as possible to meet the unmet needs of Chinese patients and healthcare professionals.”

Leveraging the CIIE Effect to Accelerate "Exhibits to Commercial Products"

The China International Import Expo (CIIE) serves not only as a window to showcase new products and technologies, but also as a platform connecting multiple stakeholders to accelerate collaboration. Riding the momentum of the CIIE, Boston Scientific has achieved "twin achievements" in recent years by deepening local partnerships and accelerating the introduction of innovative products.

Following its debut at the CIIE in 2019, Boston Scientific established a partnership with the Boao Lecheng International Medical Tourism Pilot Zone. This collaboration subsequently initiated a series of in-depth initiatives, including regulatory pilot programs and Real-World Data (RWD) studies, aimed at alleviating patient suffering and advancing the practical application of innovative review and approval pathways. In 2020, just one month after its debut at the third CIIE, the first procedure in China using the *Rezūm thermal ablation system for the treatment of benign prostatic hyperplasia (BPH) was successfully performed at Lecheng. To date, the product has successfully treated 55 patients and is slated for a pre-market launch at this year's CIIE.

Boston Scientific Rezūm Thermal Therapy Ablation System

In March this year, Boston Scientific signed an agreement with a domestic strategic partner to transfer the technology of its "hit" product from its inaugural exhibition—the *TheraSphere Y90 glass microspheres for internal radiation therapy of liver cancer—to Chengdu Newrate Medical Technology Co., Ltd. This initiative marks the first step in localizing the production of CIIE-exhibited products and represents a significant milestone in Boston Scientific's deepened strategic layout in western China.

Deepening Local Innovation, Driving High-Quality Development: A Health Community

Leveraging the CIIE platform to accelerate the transformation of "exhibits into commercial products" is a microcosm of Boston Scientific's steadfast commitment to deeply cultivating the Chinese market. Since entering China over two decades ago, the company has actively explored a localized development path while sparing no effort to empower the healthy development of the domestic healthcare ecosystem. Through professional education and training, grassroots public welfare initiatives, and other activities, it collaborates to build a health community driven by high-quality development.

To enhance the accessibility of high-quality medical resources, Boston Scientific has launched its Western Development Strategy, establishing a "Second Headquarters" in Chengdu, alongside a Western Logistics Center, an Innovation Center, and a Manufacturing and R&D Center. These initiatives aim to support the western region in developing a leading hub for the modern healthcare and pharmaceutical industry, ensuring that internationally advanced medical services reach grassroots patients in the west. Additionally, through sustained public welfare outreach programs—featuring free clinics by renowned physicians, academic lectures, and hands-on surgical training—the company is dedicated to strengthening medical service capabilities in underdeveloped areas.

To bridge the "last mile" in primary care physician training, Boston Scientific has launched the industry's first mobile education and training bus. Through interactive training and 5G remote live streaming, the initiative has brought cutting-edge medical technologies to dozens of grassroots regions. At this year's CIIE, Boston Scientific's mobile education and training bus will make its debut by "driving" directly to the exhibition booth, showcasing the tangible outcomes of its pioneering efforts to empower local talent development through innovative professional education and enhance primary healthcare service capacity.

At the outset of the 14th Five-Year Plan period, Boston Scientific's development in China has entered a new phase. The company will continue to implement its localization strategy, leverage the spillover effects of the China International Import Expo (CIIE), accelerate the introduction of innovative technologies and products, and deepen local partnerships. It will bring Chinese patients and healthcare professionals more minimally invasive interventional solutions that improve quality of life, collaborate with partners across sectors to drive the development and upgrading of China's healthcare industry, promote the nationwide sharing of high-quality medical resources, and contribute to the Healthy China initiative.

*This product has not yet been marketed in mainland China.

About Boston Scientific

Boston Scientific Corporation is committed to innovating for life. We are dedicated to developing innovative medical solutions that improve the lives of patients worldwide. For more than 40 years, Boston Scientific has consistently led the advancement of the global medical technology industry by providing a broad portfolio of high-performance medical solutions to address patients' unmet treatment needs and reduce healthcare costs. For more information, please visit our corporate website:www.bostonscientific.cn

About Boston Scientific Greater China

Boston Scientific established its China headquarters in Shanghai in 1997, and currently operates branch offices in Beijing, Shanghai, Guangzhou, Chengdu, Hong Kong, and Taiwan. The company’s core business areas encompass interventional cardiology, structural heart, cardiac rhythm management and electrophysiology, endoscopy, peripheral and interventional oncology, urology and pelvic health, and respiratory products. Upholding its tradition as an innovation leader, Boston Scientific is committed to becoming a respected medical technology company that is closely aligned with the needs of healthcare professionals and patients, and driven by continuous innovation, by delivering high-quality medical products and services for prevention, diagnosis, and treatment. For more information, please visit the company website:www.bostonscientific.cn